Newstral
Article
Forbes on 2017-03-28 18:00
Regeneron's New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing
Related news
- The unemployment rate rose — here's why that's a good thingNew York Post
- Airlines Remain As Leveraged To Fuel Price Swings As Ever, And Right Now That's A Good ThingForbes
- BRegeneron's Covid-19 Antibody Could See Substantially Higher Sales This Year. Here's Why.barrons.com
- Here's a Thing: Obama's Unstoppable Text Messageswsj.com
- MHere's 1 big retailer that's not getting Amazon-edmoney.cnn.com
- MGoldman loses its Wall Street luster as earnings disappoint, UnitedHealth’s stock soars toward record price gainmarketwatch.com
- Here's a Thing: Google Maps' Secret Weaponwsj.com
- Here's a Thing: Coders Can Skip Collegewsj.com
- Everyone Speaks English: Why That's Not Necessarily A Good ThingForbes
- Addy's is Back, and That's a Good Thing For Everyoneclevescene.com
- The Fed is Nervous, and Maybe That's a Good ThingForbes
- Here's The Worst Thing That's Ever Happened At Disneylandhuffingtonpost.com
- How To Fail At Retirement: What Almost Everyone Does Wrong That's Costing Them MoneyForbes
- The Turnaround Practice is Dead. Why That's Not a Good ThingInc.
- MRegeneron's stock rallies toward a record after profit, revenue beat expectationsmarketwatch.com
- PIf Sea Level Rises, 'Climate Migrants' May Flood Phoenix: Here's Why That's a Good Thingphoenixnewtimes.com
- Opinion: Joe Biden is old. Here's why that's a good thingCNN
- BBright Horizons Stock Is 18% Off Prepandemic Level. Here's Why That's a Bargain.3 minbarrons.com
- Dial-Up Internet is a Still Thing in Rural America. Why That's a Problem (For Everyone)Inc.
- Hillary Clinton Is Focusing on the Middle Class—And That's a Good ThingMother Jones